Live Analyst Rating Changes 23961 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Marlene Eibensteiner
DB

Marlene Eibensteiner

Wall Street Analyst
★★★★★
#208
on 13Foresight · ranked by our own returns
88%
Success Rate
+14.7%
Average Return
15 of 17 calls profitable · +4.5% vs benchmark
S&P 500 (SPY)
📈 Across the calls we could measure, roughly 88% of Marlene Eibensteiner's ratings turned a profit when each position was held for 1 year — averaging +14.7% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

18 Buy 5 Hold 0 Sell
Marlene's Stock Coverage 13 ratings · 2026-08-13
Company Date Position Consensus Price Target 1-Yr Return vs S&P 500
GB:0NXR
Raiffeisen Bank International
Aug 04, 2026 HOLD Hold
-41.4% avg upside
11 analysts
$46.00
24.88% Downside
· ·
SE:SWED.A
Swedbank
Jul 30, 2026 BUY Sell
-25.7% avg upside
9 analysts
$388.00
1.77% Upside
+1.1% ·
GB:0O84
DNB ASA
Jul 30, 2026 HOLD Hold
-6.4% avg upside
10 analysts
$298.00
2.83% Downside
· ·
GB:0NVC
Danske Bank
Jul 30, 2026 BUY Strong Buy
+6.2% avg upside
14 analysts
$388.00
4.83% Upside
· ·
DE:0B2
BAWAG Group AG
Jul 22, 2026 BUY Strong Buy
-32.1% avg upside
14 analysts
$191.00
5.95% Upside
+6.9% ·
EBKOF
Erste Group Bank
Jul 20, 2026 BUY Strong Buy
-23.3% avg upside
16 analysts
$144.06
3.33% Upside
+12.0% ·
NBNKF
Nordea Bank Abp
Jul 17, 2026 BUY Buy
-20.1% avg upside
13 analysts
$21.90
9.38% Upside
+9.3% ·
SE:SEB.A
Skandinaviska Enskilda Banken AB
Apr 13, 2026 HOLD Sell
-21.3% avg upside
7 analysts
$190.00
14.97% Downside
+21.4% ·
GB:NLB
Nova Ljubljanska Banka dd
Aug 12, 2025 BUY Strong Buy
+42.2% avg upside
2 analysts
$38.00
15.49% Downside
· ·
SE:SHB.A
Svenska Handelsbanken AB
Jul 02, 2025 HOLD Buy
-20.3% avg upside
11 analysts
$118.00
20.25% Downside
+28.3% ·
SWDBY
Swedbank AB
Jul 01, 2025 HOLD Buy
3 analysts
+55.0% ·
DE:PBB
Deutsche Pfandbriefbank
Mar 12, 2025 HOLD Buy
+150.2% avg upside
12 analysts
$6.00
65.22% Upside
-47.9% ·
CH:CMBN
Cembra Money Bank AG
Feb 23, 2024 HOLD Hold
-5.8% avg upside
3 analysts
$77.00
10.46% Downside
+33.4% ·
🔒 8 more ratings — with price targets, crowd consensus and our measured returns.
Free account unlocks every analyst's full coverage table.
Marlene Eibensteiner — Frequently Asked Questions
How accurate are Marlene Eibensteiner's stock ratings?
Based on the calls 13Foresight could measure, about 88% of Marlene's ratings were profitable over a one-year hold, with an average return of +14.7% per rating, or +4.5% versus the S&P 500. We score every analyst the same way, from historical prices. Each return is measured in the stock's own trading currency, so for non-US listings the S&P 500 comparison leaves out currency moves.
How is Marlene ranked on 13Foresight?
Marlene Eibensteiner is currently ranked #208 with a 5-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Marlene cover?
Marlene most recently has ratings on GB:0NXR, SE:SWED.A, GB:0O84, GB:0NVC, DE:0B2, EBKOF, NBNKF, SE:SEB.A, GB:NLB, SE:SHB.A, SWDBY, DE:PBB and 1 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.